
Please try another search
Hubei Goto Biopharm Co.,Ltd. engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally. It offers starting materials, such as androstenedione, bisnordiol, and 9-hydroxyandrostenedione; intermediates, including sex hormone, progesterone, corticosteroid, and other pharmaceutical raw materials. The company was founded in 2006 and is based in Xiangyang, China.
Name | Age | Since | Title |
---|---|---|---|
Minglei Li | 47 | 2018 | Non Independent Director & Deputy GM |
Jianjun Jiang | 59 | 2018 | Chairman of the Supervisory Board |
Xueming Wang | 53 | 2021 | Non Independent Director |
Qingfu Zhang | 57 | 2018 | Non-Employee Supervisor |
Xiangdong Liu | 50 | 2018 | CFO & Non-Independent Director |
Fei Qi | - | 2024 | Independent Director |
Huan Cao | - | 2024 | Non-employee supervisor |
Deliang He | - | 2024 | Independent Director |
Ziwu Long | - | 2024 | Independent Director |
Zubin Xi | 54 | 2018 | Chairman of the Board, GM, & Research and Development Director |
Wei Ren | 39 | 2018 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review